BCBA/DHRD (BCBA/DHRD)

Buenos Aires Stock Exchange: BCBA/DHRD · USD

$4.34

+0.31 (+7.6%)· Recorded snapshot

Market cap	251.1T
Revenue (ttm)	39T
Net income (ttm)	6.6T
EPS (ttm)	$174
P/E (trailing)	38.4x
P/E (forward)	25.4x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 39T
Net income (ttm): 6.6T
EPS (ttm): $174
P/E (trailing): 38.4x
P/E (forward): 25.4x
Market cap: 251.1T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E25.4

P25 n/aP50 n/aP75 n/a

Trailing P/E38.4

P25 n/aP50 n/aP75 n/a

ROE8.2

P25 n/aP50 n/aP75 n/a

ROIC6.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All BCBA/DHRD indicators

Market & fundamental data

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-10-21
Employees	59,000
Employees change	-3,000
Employees growth	-4.76%
Enterprise value	$285.1T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-09-25
First seen	2026-09-20
Fiscal year end	December
Founded	1969
Industry	Diagnostics & Research
Is primary listing	No
ISIN number	AR0002457668
Last earnings date	2026-10-21
Last refreshed	2026-10-28
Market cap	$251.1T
Price	$4.34
Price currency	USD
Sector	Healthcare
SIC code	3826
Stock price date	2026-09-29
Symbol	bcba/DHRD
Website	https://www.danaher.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	34.56x
Average P/E ratio (3Y)	40.42x
Average P/E ratio (5Y)	36.35x
Earnings yield	2.6%
EV/Earnings	43.2x
EV/EBIT	32.94x
EV/EBITDA	21.59x
EV/FCF	32.67x
EV/Sales	7.24x
FCF / EV yield	3.06%
FCF yield	3.48%
Forward P/E	25.39x
Graham number	1.90392
Graham upside	-56.13%
Lynch fair value	$0.57
Lynch upside	-86.86%
P/(FCF - SBC) ratio	30.53x
P/(OCF - SBC) ratio	25.24x
P/B ratio	3.07x
P/E ratio	38.4x
P/FCF ratio	28.77x
P/OCF ratio	24.03x
P/S ratio	6.44x
Price/EBITDA ratio	19.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	21.97%
EBITDA margin	32.24%
Effective tax rate	10.98%
FCF margin	22.16%
Gross margin	59.36%
Operating margin	21.97%
Pretax margin	18.81%
Profit margin	16.91%
Profit per employee	$111.8M
Profitable quarters	98
Profitable years	33
Revenue per employee	$661.3M
ROA	4.06%
ROA (5Y)	4.66%
ROCE	6.68%
ROE	8.19%
ROE (5Y)	9.78%
ROIC	6.6%
ROIC (5Y)	8.05%
SBC / revenue	1.28%
Tax / revenue	2.07%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	25.42%
EPS growth (Q)	37.77%
EPS growth (QoQ)	42.25%
EPS growth 10Y	5.5%
EPS growth 3Y	-8.35%
EPS growth 5Y	-4.99%
EPS growth quarters	5
EPS growth years	0
FCF growth	14.15%
FCF growth 3Y	-5.76%
FCF growth 5Y	-4.09%
Gross profit growth	5.11%
Gross profit growth (Q)	12.77%
Gross profit growth 3Y	6.93%
Gross profit growth 5Y	-2.4%
Net income growth	23.64%
Net income growth (Q)	36.01%
Net income growth (QoQ)	41.95%
Net income growth 3Y	-9.66%
Net income growth 5Y	-5.42%
Net income growth quarters	5
Net income growth years	0
OCF growth	8.56%
OCF growth 10Y	5.27%
OCF growth 3Y	-5.34%
OCF growth 5Y	-3.62%
Operating income growth	7.1%
Operating income growth (Q)	10.27%
Operating income growth 3Y	3.87%
Operating income growth 5Y	-6.08%
Revenue growth	5.52%
Revenue growth (Q)	8.28%
Revenue growth (QoQ)	4.61%
Revenue growth 10Y	4.42%
Revenue growth 3Y	6.79%
Revenue growth 5Y	-1.82%
Revenue growth quarters	6
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1.7T
Depreciation and amortization	$4T
EBIT	$8.6T
EBITDA	$12.6T
EPS	$173.79
Financing cash flow	$12.8T
Free cash flow	$8.7T
Free cash flow minus SBC	$8.2T
Gross profit	$23.2T
Income taxes	$805.9B
Investing cash flow	$-16.9T
Net borrowing	$15.8T
Net cash flow	$6.3T
Net income	$6.6T
Operating cash flow minus SBC	$9.9T
Operating income	$8.6T
Revenue	$39T
Stock-based compensation	$501.2B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.47
Book value per share	$116,138.18
Debt / EBITDA	3.24
Debt / equity	0.52
Debt / FCF	4.85
Goodwill	$72.7T
Interest coverage	15.63
Long-term assets	$119.4T
Long-term liabilities	$46.5T
Net cash (debt)	$-33.7T
Net cash / market cap	-13.41%
Net debt / EBITDA	2.68
Net debt / equity	0.41
Net debt / FCF	3.86
Piotroski F-Score	5
Property, plant and equipment	$10.7T
Shareholders' equity	$81.7T
Tangible book value	$-22.5T
Tangible book value per share	$-31,938.48
Total assets	$142.1T
Total cash	$8.7T
Total debt	$42.3T
Total liabilities	$60.4T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.3
Current assets	$22.7T
Current liabilities	$13.9T
Current ratio	1.63
Inventory turnover	3.58
Net working capital	$3.3T
Quick ratio	1.19
Working capital	$8.7T
Working capital turnover	8,651.47

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.6%
Payout ratio	23.46%
Shareholder yield	1.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	7.56%
1M price change	14.82%
1M total return	14.82%
1Y price change	18.58%
1Y return CAGR	18.59%
1Y total return	18.58%
20-day SMA	$3.78
3M price change	16.67%
3M total return	16.67%
52-week high	$4.50
52-week high date	2026-01-14
52-week low	$3.23
52-week low date	2026-05-07
6M price change	21.57%
6M total return	21.57%
All-time high	$4.66
All-time high date	2025-01-28
All-time low	$3.23
All-time low date	2026-05-07
Average true range (ATR)	$0.21
Average volume	17.6
Change from 52-week high	-3.45%
Change from 52-week low	34.37%
Change from all-time high	-6.93%
Change from all-time low	34.37%
Change from open	-0.57%
Day's gap	8.18%
High price	$4.37
Low price	$4.34
Monthly RSI	53.17
Open price	$4.37
Position in 52-week range	0%
Previous close	$4.04
Price vs 20-day SMA	14.94%
Relative volume	0.06
RSI	53.8
Sharpe ratio	-0.2
Sortino ratio	-0.23
Weekly RSI	0
YTD price change	1.17%
YTD total return	1.17%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	626.3M
Shares change (QoQ)	-0.11%
Shares change (YoY)	-1.6%
Shares held by insiders	10.86%
Shares held by institutions	83.38%
Short ratio	1.9 days

Deeper analysis on BCBA/DHRD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this BCBA/DHRD report

Is a complete BCBA/DHRD research report available?

No complete published report is available for bcba/DHRD (BCBA/DHRD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

251.1T

Revenue (ttm)

39T

Net income (ttm)

6.6T

EPS (ttm)

$174

P/E (trailing)

38.4x

P/E (forward)

25.4x

Metric

Value

Amount currency

ARS

Country

United States

Country code

Earnings date

2026-10-21

Employees

59,000

Employees change

-3,000

Employees growth

-4.76%

Enterprise value

$285.1T

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-09-25

First seen

2026-09-20

Fiscal year end

December

Founded

1969

Industry

Diagnostics & Research

Is primary listing

ISIN number

AR0002457668

Last earnings date

2026-10-21

Last refreshed

2026-10-28

Market cap

$251.1T

Price

$4.34

Price currency

USD

Sector

Healthcare

SIC code

3826

Stock price date

2026-09-29

Symbol

bcba/DHRD

Website

https://www.danaher.com

Metric

Value

Average P/E ratio (10Y)

34.56x

Average P/E ratio (3Y)

40.42x

Average P/E ratio (5Y)

36.35x

Earnings yield

2.6%

EV/Earnings

43.2x

EV/EBIT

32.94x

EV/EBITDA

21.59x

EV/FCF

32.67x

EV/Sales

7.24x

FCF / EV yield

3.06%

FCF yield

3.48%

Forward P/E

25.39x

Graham number

1.90392

Graham upside

-56.13%

Lynch fair value

$0.57

Lynch upside

-86.86%

P/(FCF - SBC) ratio

30.53x

P/(OCF - SBC) ratio

25.24x

P/B ratio

3.07x

P/E ratio

38.4x

P/FCF ratio

28.77x

P/OCF ratio

24.03x

P/S ratio

6.44x

Price/EBITDA ratio

19.96x

Metric

Value

EBIT margin

21.97%

EBITDA margin

32.24%

Effective tax rate

10.98%

FCF margin

22.16%

Gross margin

59.36%

Operating margin

21.97%

Pretax margin

18.81%

Profit margin

16.91%

Profit per employee

$111.8M

Profitable quarters

Profitable years

Revenue per employee

$661.3M

ROA

4.06%

ROA (5Y)

4.66%

ROCE

6.68%

ROE

8.19%

ROE (5Y)

9.78%

ROIC

6.6%

ROIC (5Y)

8.05%

SBC / revenue

1.28%

Tax / revenue

2.07%

Metric

Value

EPS growth

25.42%

EPS growth (Q)

37.77%

EPS growth (QoQ)

42.25%

EPS growth 10Y

5.5%

EPS growth 3Y

-8.35%

EPS growth 5Y

-4.99%

EPS growth quarters

EPS growth years

FCF growth

14.15%

FCF growth 3Y

-5.76%

FCF growth 5Y

-4.09%

Gross profit growth

5.11%

Gross profit growth (Q)

12.77%

Gross profit growth 3Y

6.93%

Gross profit growth 5Y

-2.4%

Net income growth

23.64%

Net income growth (Q)

36.01%

Net income growth (QoQ)

41.95%

Net income growth 3Y

-9.66%

Net income growth 5Y

-5.42%

Net income growth quarters

Net income growth years

OCF growth

8.56%

OCF growth 10Y

5.27%

OCF growth 3Y

-5.34%

OCF growth 5Y

-3.62%

Operating income growth

7.1%

Operating income growth (Q)

10.27%

Operating income growth 3Y

3.87%

Operating income growth 5Y

-6.08%

Revenue growth

5.52%

Revenue growth (Q)

8.28%

Revenue growth (QoQ)

4.61%

Revenue growth 10Y

4.42%

Revenue growth 3Y

6.79%

Revenue growth 5Y

-1.82%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

$-1.7T

Depreciation and amortization

$4T

EBIT

$8.6T

EBITDA

$12.6T

EPS

$173.79

Financing cash flow

$12.8T

Free cash flow

$8.7T

Free cash flow minus SBC

$8.2T

Gross profit

$23.2T

Income taxes

$805.9B

Investing cash flow

$-16.9T

Net borrowing

$15.8T

Net cash flow

$6.3T

Net income

$6.6T

Operating cash flow minus SBC

$9.9T

Operating income

$8.6T

Revenue

$39T

Stock-based compensation

$501.2B

Metric

Value

Altman Z-Score

3.47

Book value per share

$116,138.18

Debt / EBITDA

3.24

Debt / equity

0.52

Debt / FCF

4.85

Goodwill

$72.7T

Interest coverage

15.63

Long-term assets

$119.4T

Long-term liabilities

$46.5T

Net cash (debt)

$-33.7T

Net cash / market cap

-13.41%

Net debt / EBITDA

2.68

Net debt / equity

0.41

Net debt / FCF

3.86

Piotroski F-Score

Property, plant and equipment

$10.7T

Shareholders' equity

$81.7T

Tangible book value

$-22.5T

Tangible book value per share

$-31,938.48

Total assets

$142.1T

Total cash

$8.7T

Total debt

$42.3T

Total liabilities

$60.4T

Metric

Value

Asset turnover

0.3

Current assets

$22.7T

Current liabilities

$13.9T

Current ratio

1.63

Inventory turnover

3.58

Net working capital

$3.3T

Quick ratio

1.19

Working capital

$8.7T

Working capital turnover

8,651.47

Metric

Value

Buyback yield / dilution

1.6%

Payout ratio

23.46%

Shareholder yield

1.6%

Metric

Value

1D price change

7.56%

1M price change

14.82%

1M total return

14.82%

1Y price change

18.58%

1Y return CAGR

18.59%

1Y total return

18.58%

20-day SMA

$3.78

3M price change

16.67%

3M total return

16.67%

52-week high

$4.50

52-week high date

2026-01-14

52-week low

$3.23

52-week low date

2026-05-07

6M price change

21.57%

6M total return

21.57%

All-time high

$4.66

All-time high date

2025-01-28

All-time low

$3.23

All-time low date

2026-05-07

Average true range (ATR)

$0.21

Average volume

17.6

Change from 52-week high

-3.45%

Change from 52-week low

34.37%

Change from all-time high

-6.93%

Change from all-time low

34.37%

Change from open

-0.57%

Day's gap

8.18%

High price

$4.37

Low price

$4.34

Monthly RSI

53.17

Open price

$4.37

Position in 52-week range

Previous close

$4.04

Price vs 20-day SMA

14.94%

Relative volume

0.06

RSI

53.8

Sharpe ratio

-0.2

Sortino ratio

-0.23

Weekly RSI

YTD price change

1.17%

YTD total return

1.17%

Metric

Value

Float

626.3M

Shares change (QoQ)

-0.11%

Shares change (YoY)

-1.6%

Shares held by insiders

10.86%

Shares held by institutions

83.38%

Short ratio

1.9 days

BCBA/DHRD (BCBA/DHRD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/DHRD

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All BCBA/DHRD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/DHRD

Frequently asked questions

BCBA/DHRD (BCBA/DHRD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/DHRD

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All BCBA/DHRD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/DHRD

Frequently asked questions